JPMorgan Chase & Co. Sells 49,921 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

JPMorgan Chase & Co. lessened its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 21.8% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 178,923 shares of the semiconductor company’s stock after selling 49,921 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.55% of Axcelis Technologies worth $18,760,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Xponance Inc. lifted its stake in Axcelis Technologies by 4.7% during the 2nd quarter. Xponance Inc. now owns 2,061 shares of the semiconductor company’s stock valued at $293,000 after acquiring an additional 92 shares in the last quarter. Evergreen Capital Management LLC raised its holdings in shares of Axcelis Technologies by 6.1% in the second quarter. Evergreen Capital Management LLC now owns 1,984 shares of the semiconductor company’s stock valued at $282,000 after purchasing an additional 114 shares during the last quarter. Nisa Investment Advisors LLC lifted its position in shares of Axcelis Technologies by 11.9% during the third quarter. Nisa Investment Advisors LLC now owns 1,069 shares of the semiconductor company’s stock valued at $112,000 after purchasing an additional 114 shares in the last quarter. Crossmark Global Holdings Inc. grew its position in Axcelis Technologies by 5.8% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 2,398 shares of the semiconductor company’s stock worth $251,000 after purchasing an additional 132 shares in the last quarter. Finally, Arizona State Retirement System grew its position in Axcelis Technologies by 1.5% in the 2nd quarter. Arizona State Retirement System now owns 9,134 shares of the semiconductor company’s stock worth $1,299,000 after purchasing an additional 134 shares in the last quarter. Hedge funds and other institutional investors own 89.98% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on ACLS shares. Needham & Company LLC restated a “hold” rating on shares of Axcelis Technologies in a research note on Friday, November 8th. Benchmark cut Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Friday, November 8th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $167.33.

Axcelis Technologies Trading Down 0.8 %

NASDAQ:ACLS opened at $73.10 on Friday. Axcelis Technologies, Inc. has a 12 month low of $68.23 and a 12 month high of $158.61. The company has a current ratio of 4.45, a quick ratio of 3.29 and a debt-to-equity ratio of 0.04. The firm’s 50 day moving average is $75.48 and its 200 day moving average is $100.00. The stock has a market capitalization of $2.38 billion, a PE ratio of 10.81, a price-to-earnings-growth ratio of 2.36 and a beta of 1.53.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.